Meridian Sees Q1 Below Estimates

Medical diagnostic kit maker Meridian Bioscience Inc’s projected lower-than-expected first-quarter earnings and cut its revenue outlook for the year, as the strong dollar was hurting its European diagnostics sales.
TradingMarkets